Skip to main content
Genetics and Molecular Biology logoLink to Genetics and Molecular Biology
. 2009 Sep 1;32(3):466–469. doi: 10.1590/S1415-47572009000300007

Mutation and association analysis of the PVR and PVRL2 genes in patients with non-syndromic cleft lip and palate

Mehmet A Sözen 1,3,, Jacqueline T Hecht 2, Richard A Spritz 3
PMCID: PMC3036061  PMID: 21637507

Abstract

Orofacial clefts (OFC; MIM 119530) are among the most common major birth defects. Here, we carried out mutation screening of the PVR and PVRL2 genes, which are both located at an OFC linkage region at 19q13 (OFC3) and are closely related to PVRL1, which has been associated with both syndromic and non-syndromic cleft lip and palate (nsCLP). We screened a total of 73 nsCLP patients and 105 non-cleft controls from the USA for variants in PVR and PVRL2, including all exons and encompassing all isoforms. We identified four variants in PVR and five in PVRL2. One non-synonymous PVR variant, A67T, was more frequent among nsCLP patients than among normal controls, but this difference did not achieve statistical significance.

Keywords: PVR, PVRL2, cleft lip and palate, mutation, SSCP


Orofacial clefts (OFC) are common birth defects, occurring in approximately 1 per 800 North American Caucasian infants and varying in incidence among patients of different geographical origins (Vanderas, 1987). Most cases of OFC (70%) occur sporadically, and may include isolated cleft lip, cleft lip with or without palate (CLP) and isolated cleft palate. Such ‘non-syndromic' OFC appear to be polygenic in origin, a number of loci each exerting a relatively modest effect against a multi-factorial background (Spritz, 2001; Murray, 2002; Cobourne, 2004).

A role for one or more genes at chromosome 19q involved in non-syndromic CLP (nsCLP) has been supported by multiple lines of evidence. Genetic linkage studies defined OFC3, a region of genetic linkage to nsCLP on chromosome 19q13 (Stein et al., 1995; Warrington et al., 2006). Initial studies of candidate genes in the OFC3 region focused on BCL3, a number of genetic association studies finding conflicting evidence of association with nsCLP in various populations (Stein et al., 1995; Amos et al., 1996; Maestri et al., 1997; Gaspar et al., 2002; Blanco et al., 2004). Other genes studied in the OFC3 region include APOC2 (Marazita et al., 2002), CLPTM1 (Yoshiura et al.,1998; Turhani et al., 2005; Warrington et al., 2006), and TOMM40 (Warrington et al., 2006), each yielding, at best, inconsistent evidence for involvement in nsCLP.

Recent attention has turned to two other candidate genes in 19q13, PVR and PVRL2, which are paralogous to PVRL1, in which homozygous mutations result in a rare autosomal recessive CLP syndrome, CLPED1 (Suzuki et al., 2000), and in which variants have been genetically associated with nsCLP in northern Venezuela (Sözen et al., 2001) and perhaps other populations (Avila et al., 2006; Scapoli et al., 2006; Tongkobpetch et al., 2008). PVR, PVRL1, and PRVL2 respectively encode Necl-5/CD155, nectin-1 and nectin-2, cell adhesion molecules present at adherens junctions and other ectoplasmic specializations at cell-cell contacts (Young et al., 2009), and are widely expressed during development. Warrington et al. (2006) reported genetic association of a rare intronic variant in PVR, C__1828143_10 (rs35385129), with nsCLP in patients from several different populations, and by direct sequencing identified 7 variants in PVR and 16 in PVRL2, none of which appeared to be causal for nsCLP. A subsequent study found marginal association of nsCLP in Italian patients with PVR SNP rs35385129, but no association with a single intronic PVRL2 SNP analyzed (Pezzetti et al., 2007).

In the present study, we carried out mutation analyses of PVR and PVRL2 in USA Caucasian (CEU) patients with nsCLP and non-cleft controls. We obtained genomic DNA samples with informed consent from USA patients with nsCLP but with no other physical or cognitive abnormalities, and from unaffected controls. We initially screened all 8 exons of PVR and 10 exons of PVRL2 (encompassing all known mRNA isoforms, except the last 21 nt of PVRL2 exon 1) in 73 unrelated USA CEU nsCLP patients and 105 unrelated USA CEU controls. Subsequently, an additional 28 unrelated USA CEU nsCLP patients were specifically analyzed for the PVR rs1058402 (A67T) variant. The PVR and PVRL2 PCR primers used are given in Table 1. PCR products were screened for variation by simultaneous single-stranded conformation polymorphism (SSCP)/heteroduplex analysis by electrophoresis in 0.5X MDE gels (Biowhittaker Molecular Applications) containing 10% glycerol (Lee et al., 1995), followed by DNA sequence analysis of those amplicons exhibiting aberrant SSCP/heteroduplex patterns.

Table 1.

Oligonucleotide primers for PCR amplification of the exons of PVR and PVRL2.

Amplicon Primer sequences Amplicon size (bp)
PVR
Exon 1 5' AGAGCGACGGGCGCCGGGAA 3'
5' ACTGCGCGGGGGTCACTCAC 3'
165
Exon 2 5' TTCTCTTCGGTTCTCCGCAG 3'
5' CCCCAAAACCCCCTGCTC 3'
388
Exon 3 5' GCTTTTGTTCCTCTTCCCAG 3'
5' GCTGACTTGGGCACACTCAC 3'
337
Exon 4 5' TCTGTATCCATTTCCTGCAG 3'
5' CCCTGAGACCCAGGACTCAC 3'
158
Exon 5 5' CACCTTTCTGTCTCTCTCCCAG 3'
5' CCACCCAGGGAGTTCCTCAC 3'
189
Exon 6 5' CCTGTTTCCTTCTCTTTCAG 3'
5' GTAGGTGCTCAATTACGGCA 3'
216
Exon 7 5' TTCCCCTCCTATTTCCCCAG 3'
5' AGCTCCAACACTGCACTTAC 3'
72
Exon 8 5' ATTTGAAAACCCTCTTCTAG 3'
5' GGTCCAACTCTGGAGGCCCA 3'
158

PVRL2
Exon 1 5' CTACTAAACCGCCCAGCCGA 3'
5' CGGTTTCCAGGAGCAGCAGC 3'
169
Exon 2 5' GTGGCCCTGCCTGGAGGTGT 3'
5' TGACCCGCAAGGGGATGCTC 3'
530
Exon 3 5' CTCCTCTGCTGAGTGTTTGT 3'
5' GTAGACAGTGCTTTAGAGAA 3'
437
Exon 4 5' CTATCTGCTAACTTGTCCAC 3'
5' TTAGATCCAGGAGTCCAGGC 3'
258
Exon 5 5' TCTTTAGGGATGAGGCCTGTG 3'
5' AAGTCCTGAAGGGCAGAACT 3'
290
Exon 6 5' CCCAGAGCGATCCTCGTGAT 3'
5' AACCAGTCTGGAACCCTAGG 3'
550
Exon 7 5' GATGGTCGCTTGGAATAAGG 3'
5' CTCACCCTACCCCATACTC 3'
295
Exon 8 5' GTGCCATAACCCCGGAGTCA 3'
5' GCCAGGCCCCTCCCAGCCCT 3'
205
Exon 9 5' GGCCTGGCAGGGAGAAGCTG 3'
5' TTGCCAGGCTTGACCCCTGG 3'
228
Exon 10 5' AAGAGCAGATTGGTAATCTG 3'
5' GGCACTAGATCCTTGGCAAG 3'
411

As shown in Table 2, we identified a total of four variants in PVR: rs11540085 (-1C > T), rs1058402 (A67T), rs203710 (I340M), and one novel variant, 19:49856876G > A (E404E). Similarly, we identified a total of five variants in PVRL2: rs41290128 (D496N), rs283814 (P409P) and three novel variants, 19:50077328G > A (A355T), 19:50081289T > C (F440F) and 19:50073660_50073661insAGG (R461-462ins). Most variants were observed in both patients and controls, except for the rare variant PVR 19:49856876G > A (E404E), which was observed in only one control, PVRL2 19:50077328G > A (A355T) and 19:50081289T > C (F440F), which we only observed in one and two patients, respectively, and 19:50073660_50073661insAGG (R461-462ins), which was observed in two controls. The allele frequency of the non-synonymous PVR variant, rs1058402 (A67T), in spite of being somewhat greater among nsCLP patients (0.039) than among controls (0.014), did not achieve statistical significance (p = 0.098). Likewise, genotype frequency distribution of the rs1058402 variant was not significantly different between nsCLP patients and controls.

Table 2.

PVR and PVRL2 variants observed in USA CEU nsCLP patients and controls.

Variants* Allele frequency
Genotype frequency***
Cases Controls p-value** Cases
Controls
p-value***
11 12 22 11 12 22
PVR
rs11540085
(-1C > T)
1/146 (0.007) 1/210 (0.005) 0.653 72 1 0 102 3 0 0.645
rs1058402
(A67T)
8/202 (0.039) 3/210 (0.014) 0.098 94 6 1 102 3 0 0.245
rs203710
(I340M)
4/146 (0.027) 3/206 (0.015) 0.317 69 4 0 100 3 0 0.451
19:49856876G > A
(E404E)
0/146
(0)
1/178 (0.006) 0.549 73 0 0 88 1 0 1.000

PVRL2
19:50077328G > A
(A355T)
1/144 (0.007) 0/144
(0)
0.500 71 1 0 72 0 0 1.000
rs283814
(P409P)
3/144 (0.068) 1/144 (0.007) 0.311 69 3 0 71 1 0 0.620
19:50081289T > C
(F440F)
2/144 (0.027) 0/202
(0)
0.173 70 2 0 101 0 0 0.172
19:50073660_50073661insAGG (R461-462ins) 0/146
(0)
2/206 (0.001) 0.342 73 0 0 101 2 0 0.512
rs41290128
(D496N)
2/144 (0.027) 2/202 (0.001) 0.553 70 2 0 99 2 0 1.000

*Nucleotide positions are referent to NCBI Build 36 (November, 2005), release 38 (April, 2006).

**2X2 Fisher's exact test, 1-tailed assuming that the minor allele tags a potential risk variant.

***For each SNP, the major allele was designated 1 and the minor allele was designated 2; 2X3 Freeman-Halston extension of Fisher's exact test, 2-tailed.

p-values are given without Bonferroni correction.

The etiology of orofacial clefts is complex, most likely involving many different genetic and environmental factors, most of which remain unknown. Genetic association and linkage, besides studies, have implicated a region in chromosome 19q13, termed OFC3. Warrington et al. (2006) reported genetic association between nsCLP and a rare intronic variant in PVR, rs35385129, in two distinct populations, although no association was found in two other patient groups (Warrington et al., 2006; Pezzetti et al., 2007). In spite of the statistically non-significant results here reported, our data suggest that PVR may bear further investigation.

Acknowledgments

This work was supported by National Institutes of Health grant DE13571 to R.A.S. We thank Drs. Iain McIntosh and Jeff Murray for contributing patient samples.

Footnotes

Associate Editor: Paulo A. Otto

References

  1. Amos C., Gasser D., Hecht J.T. Nonsyndromic cleft lip with or without cleft palate: New BCL3 information. Am J Hum Genet. 1996;59:743–744. [PMC free article] [PubMed] [Google Scholar]
  2. Avila J.R., Jezewski P.A., Vieira A.R., Orioli I.M., Castilla E.E., Christensen K., Daack-Hirsch S., Romitti P.A., Murray J.C. PVRL1 variants contribute to non-syndromic cleft lip and palate in multiple populations. Am J Med Genet. 2006;140:2562–2570. doi: 10.1002/ajmg.a.31367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blanco R., Suazo J., Santos J.L., Paredes M., Sung H., Carreño H., Jara L. Association between 10 microsatellite markers and nonsyndromic cleft lip palate in the Chilean population. Cleft Palate Craniofac J. 2004;41:163–167. doi: 10.1597/02-147. [DOI] [PubMed] [Google Scholar]
  4. Cobourne M.T. The complex genetics of cleft lip and palate. Eur J Orthod. 2004;26:7–16. doi: 10.1093/ejo/26.1.7. [DOI] [PubMed] [Google Scholar]
  5. Gaspar D.A., Matioli S.R., Pavanello R.C., Araujo B.C., Andre M., Steman S., Otto P.A., Passos-Bueno M.R. Evidence that BCL3 plays a role in the etiology of nonsyndromic oral clefts in Brazilian families. Genet Epidemiol. 2002;23:364–374. doi: 10.1002/gepi.10189. [DOI] [PubMed] [Google Scholar]
  6. Lee S.T., Park S.K., Lee K.H., Holmes S.A., Spritz R.A. A non-radioactive method for simultaneous detection of single-strand conformation polymorphisms (SSCPs) and heteroduplexes. Mol Cells. 1995;5:668–672. [Google Scholar]
  7. Maestri N.E., Beaty T.H., Hetmanski J., Smith E.A., McIntosh I., Wyszynski D.F., Liang K.Y., Duffy D.L., VanderKolk C. Application of transmission disequilibrium tests to nonsyndromic oral clefts: Including candidate genes and environmental exposures in the models. Am J Med Genet. 1997;73:337–344. doi: 10.1002/(sici)1096-8628(19971219)73:3<337::aid-ajmg21>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  8. Marazita M.L., Field L.L., Cooper M.E., Tobias R., Maher B.S., Peanchitlertkajorn S., Liu Y.E. Nonsyndromic cleft lip with or without cleft palate in China: Assessment of candidate regions. Cleft Palate Craniofac J. 2002;39:149–156. doi: 10.1597/1545-1569_2002_039_0149_nclwow_2.0.co_2. [DOI] [PubMed] [Google Scholar]
  9. Murray J.C. Gene/environment causes of cleft lip and/or palate. Clin Genet. 2002;61:248–256. doi: 10.1034/j.1399-0004.2002.610402.x. [DOI] [PubMed] [Google Scholar]
  10. Pezzetti F., Palmieri A., Martinelli M., Scapoli L., Arlotti M., Baciliero U., Padula E., Carinci P., Caramelli E., Carinci F. Linkage disequilibrium analysis of two-genes mapping on OFC3: PVR and PVRL2. Eur J Hum Genet. 2007;15:992–994. doi: 10.1038/sj.ejhg.5201868. [DOI] [PubMed] [Google Scholar]
  11. Scapoli L., Palmieri A., Martinelli M., Vaccari C., Marchesini J., Pezzetti F., Baciliero U., Padula E., Carinci P., Carinci F. Study of the PVRL1 gene in Italian nonsyndromic cleft lip patients with or without cleft palate. Ann Hum Genet. 2006;70:410–413. doi: 10.1111/j.1529-8817.2005.00237.x. [DOI] [PubMed] [Google Scholar]
  12. Sözen M.A., Suzuki K., Tolarova M.M., Bustos T., Fernández Iglesias J.E., Spritz R.A. Mutation of PVRL1 is associated with sporadic, non-syndromic cleft lip/palate in northern Venezuela. Nat Genet. 2001;29:141–142. doi: 10.1038/ng740. [DOI] [PubMed] [Google Scholar]
  13. Spritz R.A. The genetics and epigenetics of orofacial clefts. Curr Opin Pediatr. 2001;13:556–560. doi: 10.1097/00008480-200112000-00011. [DOI] [PubMed] [Google Scholar]
  14. Stein J., Mulliken J.B., Stal S., Gasser D.L., Malcolm S., Winter R., Blanton S.H., Amos C., Seemanova E., Hecht J.T. Nonsyndromic cleft lip with or without cleft palate: Evidence of linkage to BCL3 in 17 multigenerational families. Am J Hum Genet. 1995;57:257–272. [PMC free article] [PubMed] [Google Scholar]
  15. Suzuki K., Hu D., Bustos T., Zlotogora J., Richieri-Costa A., Helms J.A., Spritz R.A. Mutations of PVRL1, encoding a cell-cell adhesion molecule/herpesvirus receptor, in cleft lip/palate-ectodermal dysplasia. Nat Genet. 2000;25:427–430. doi: 10.1038/78119. [DOI] [PubMed] [Google Scholar]
  16. Tongkobpetch S., Suphapeetiporn K., Siriwan P., Shotelersuk V. Study of the poliovirus receptor related-1 gene in Thai patients with non-syndromic cleft lip with or without cleft palate. Int J Oral Maxillofac Surg. 2008;37:550–553. doi: 10.1016/j.ijom.2008.01.024. [DOI] [PubMed] [Google Scholar]
  17. Turhani D., Item C.B., Watzinger E., Sinko K., Watzinger F., Lauer G., Ewers R. Mutation analysis of CLPTM 1 and PVRL1 genes in patients with non-syndromic clefts of lip, alveolus and palate. J Craniomaxillofac Surg. 2005;33:301–306. doi: 10.1016/j.jcms.2005.04.004. [DOI] [PubMed] [Google Scholar]
  18. Vanderas A.P. Incidence of cleft lip, cleft palate, and cleft lip and palate among races: A review. Cleft Palate J. 1987;24:216–225. [PubMed] [Google Scholar]
  19. Warrington A., Vieira A.R., Christensen K., Orioli I.M., Castilla E.E., Romitti P.A., Murray J.C. Genetic evidence for the role of loci at 19q13 in cleft lip and palate. J Med Genet. 2006;43:e26. doi: 10.1136/jmg.2005.034785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Young J.S., Guttman J.A., Vaid K.S., Vogl A.W. Tubulobulbar complexes are intercellular podosome-like structures that internalize intact intercellular junctions during epithelial remodeling events in rat testes. Biol Reprod. 2009;80:162–174. doi: 10.1095/biolreprod.108.070623. [DOI] [PubMed] [Google Scholar]
  21. Yoshiura K., Machida J., Daack-Hirsch S., Patil S.R., Ashworth L.K., Hecht J.T., Murray J.C. Characterization of a novel gene disrupted by a balanced chromosomal translocation t(2;19)(q11.2;q13.3) in a family with cleft lip and palate. Genomics. 1998;54:231–240. doi: 10.1006/geno.1998.5577. [DOI] [PubMed] [Google Scholar]

Articles from Genetics and Molecular Biology are provided here courtesy of Sociedade Brasileira de Genética

RESOURCES